400 18 Synthetic Biology: From Genetic Engineering 2.0 to Responsible Research and Innovation
45 Stemerding, D., Vriend, H.D., Walhout, B., and Est, R.V. (2009) Synthetic biology
and the role of civil society rrganizations, in Synthetic Biology (ed. M. Schmidt),
Springer Science+Business Media B.V.
46 Bereswill, S., Munoz, M., Fischer, A., Plickert, R., Haag, L.M., Otto, B., Kuhl,
A.A., Loddenkemper, C., Gobel, U.B., and Heimesaat, M.M. (2010) Anti-
inflammatory effects of resveratrol, curcumin and simvastatin in acute small
intestinal inflammation. PLoS One, 5 (12), e15099.
47 ETC (2007) Extreme Genetic Engineering an Introduction to Synthetic Biology,
http://www.etcgroup.org/content/extreme-genetic-engineering-introduction-
synthetic-biology
48 ETC, Friends for the Earth and CTA (2012) The Principles for the Oversight of
Synthetic Biology, http://www.synbioproject.org/process/assets/files/6620/_
draft/principles_for_the_oversight_of_synthetic_biology.pdf
49 ETC and Heinrich Böll Foundation (2012) Biomassters Battle to Control the
Green Economy, http://www.etcgroup.org/sites/www.etcgroup.org/files/
greco_A4_eng_v16.pdf
50 ETC (2006) Global Coalition Sounds the Alarm on Synthetic Biology, http://
http://www.etcgroup.org/content/global-coalition-sounds-alarm-synthetic-biology
51 ETC (2010) The New Biomassters, http://www.etcgroup.org/content/
new-biomassters
52 Bogner, A. (2010) Let’s disagree! Talking ethics in technology controversies.
Sci. Technol. Innov. Stud., 6 (2), 183–201.
53 Simmel, G. (1958) Der Streit. Soziologie. Untersuchungen über die Formen der
Vergesellschaftung, Duncker & Humblot, Berlin.
54 Moya, A., Krasnogor, N., Pereto, J., and Latorre, A. (2009) Goethe’s dream.
Challenges and opportunities for synthetic biology. EMBO Rep., 10 (Suppl. 1),
S28–S32.
55 Ulsemer, P., Toutounian, K., Schmidt, J., Leuschner, J., Karsten, U., and Goletz, S.
(2012) Safety assessment of the commensal strain Bacteroides xylanisolvens
DSM 23964. Regul. Toxicol. Pharmacol., 62 (2), 336–346.
56 Torgersen, H. and Schmidt, M. (2013) Frames and comparators: how might a
debate on synthetic biology evolve? Futures, 48 (100), 44–54.
57 Lindgren, S. (1999) Biosafety aspects of genetically modified lactic acid bacteria
in EU legislation. Int. Dairy J., 9 , 37–41.
58 Torgersen, H. and Schmidt, M. (2012) Perspektiven der Kommunikation für die
Synthetische Biologie, in Biotechnologie-Kommunikation. Kontroversen,
Analysen, Aktivitäten, Acatech Diskussion (eds M.-D. Weitze, A. Pühler, W.M.
Heckl, et al.), Springer-Verlag, Heidelberg, p. 113.
59 IRGC (2010) Guidelines for the Appropriate Risk Governance of Synthetic
Biology, http://www.irgc.org/IMG/pdf/irgc_SB_final_07jan_web.pdf
60 Grobe, A., Eberhard, C., and Hutterli, M. (2005) Nanotechnologie im Spiegel der
Medien: Medienanalyse zur Berichterstattung uber Chancen und Risiken der
Nanotechnologie, Stiftung Risiko-Dialog, St. Gallen.
61 Sybesma, W., Hugenholtz, J., De Vos, W.M., and Smid, E.J. (2006) Safe use of
genetically modified lactic acid bacteria in food. Bridging the gap between
consumers, green groups, and industry. Electron. J. Biotechnol., 9 (4).